Patents by Inventor William James Boyle

William James Boyle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7544519
    Abstract: The present invention provides a purified polynucleotide encoding a novel polypeptide, designated Fhm, which belongs to the TNF gene superfamily; to purified Fhm polypeptide molecules; to antibodies that bind Fhm; to materials comprising such molecules; and to methods of using such molecules.
    Type: Grant
    Filed: July 13, 2004
    Date of Patent: June 9, 2009
    Assignee: Amgen Inc.
    Inventors: Hailing Hsu, Scott Kenneth Wooden, William James Boyle
  • Patent number: 6852839
    Abstract: The present invention provides a purified polynucleotide encoding a novel polypeptide, designated Fhm, which belongs to the TNF gene superfamily; to purified Fhm polypeptide molecules; to antibodies that bind Fhm; to materials comprising such molecules; and to methods of using such molecules.
    Type: Grant
    Filed: November 1, 2002
    Date of Patent: February 8, 2005
    Assignee: Amgen, Inc.
    Inventors: Hailing Hsu, Scott Kenneth Wooden, William James Boyle
  • Publication number: 20040265913
    Abstract: The present invention provides a purified polynucleotide encoding a novel polypeptide, designated Fhm, which belongs to the TNF gene superfamily; to purified Fhm polypeptide molecules; to antibodies that bind Fhm; to materials comprising such molecules; and to methods of using such molecules.
    Type: Application
    Filed: July 13, 2004
    Publication date: December 30, 2004
    Inventors: Hailing Hsu, Scott Kenneth Wooden, William James Boyle
  • Publication number: 20040248324
    Abstract: The present invention provides a purified polynucleotide encoding a novel polypeptide, designated Fhm, which belongs to the TNF gene superfamily; to purified Fhm polypeptide molecules; to antibodies that bind Fhm; to materials comprising such molecules; and to methods of using such molecules.
    Type: Application
    Filed: July 13, 2004
    Publication date: December 9, 2004
    Inventors: Hailing Hsu, Scott Kenneth Wooden, William James Boyle
  • Publication number: 20030129706
    Abstract: The present invention provides a purified polynucleotide encoding a novel polypeptide, designated Fhm, which belongs to the TNF gene superfamily; to purified Fhm polypeptide molecules; to antibodies that bind Fhm; to materials comprising such molecules; and to methods of using such molecules.
    Type: Application
    Filed: November 1, 2002
    Publication date: July 10, 2003
    Inventors: Hailing Hsu, Scott Kenneth Wooden, William James Boyle
  • Publication number: 20030103978
    Abstract: Selective binding agents of osteoprotegerin binding protein (OPGbp) are provided by the invention. More particularly, the invention provides for antibodies and antigen binding domains which selectively bind to OPGbp and may be used to prevent or treat conditions relating to loss of bone mass. Nucleic acid molecules encoding said antibodies and antigen binding domains, and expression vectors and host cells for the production of same are also provided.
    Type: Application
    Filed: February 22, 2001
    Publication date: June 5, 2003
    Applicant: Amgen Inc.
    Inventors: Rajendra V. Deshpande, Anna Hitz, William James Boyle, John K. Sullivan
  • Patent number: 6521422
    Abstract: The present invention provides a purified polynucleotide encoding a novel polypeptide, designated Fhm, which belongs to the TNF gene superfamily; to purified Fhm polypeptide molecules; to antibodies that bind Fhm; to materials comprising such molecules; and to methods of using such molecules.
    Type: Grant
    Filed: August 3, 2000
    Date of Patent: February 18, 2003
    Assignee: Amgen Inc.
    Inventors: Hailing Hsu, Scott Kenneth Wooden, William James Boyle